FORWARD FEATURES CALENDAR

Intelligence

RSK Group acquires Ecologia

RSK, a UK environmental, engineering and technical services consultancy, has acquired Ecologia Environmental Solutions Ltd. The multidisciplinary site remediation specialist is the sixth acquisition for the rapidly expanding RSK group this financial year. With headquarters in Sittingbourne, Kent, further UK offices in Stafford and Devon, and an office in Bologna,

Appetite still strong for casual dining investments despite high street challenges

Investor appetite remains strong for specific opportunities with the right dynamics in the UK’s casual dining sector – despite the current challenging conditions on the high street, according to Connection Capital, a specialist private client investment business. The firm recently completed an allocation to a management buyout (MBO) of Rosa’s

HKW portfolio company Fresh Direct Produce acquires Islands West

Fresh Direct Produce, a portfolio company of middle market private equity firm HKW, has acquired Islands West Manufacturing (Islands West). Financial terms of the transaction have not been disclosed.   Founded in 1995 and headquartered in Victoria, British Columbia, Islands West is a family-owned wholesaler of produce, processed fruits, dried spices,

Andrew Borowiec, IMDDA

IMDDA partners with Intelligo

The Investment Management Due Diligence Association (IMDDA), an investor-based organisation dedicated to the professionals who perform  investment and operational due diligence, has launched a new program giving its members access to background checks provided by Intelligo, a specialist in technology-driven background checks. This new IMDDA member-only program provides access to

LiveOak Venture Partners adds to investment team

LiveOak Venture Partners, an early-stage venture capital firm based in Austin, Texas, has appointed David Stewart as Venture Partner. Stewart will focus on sourcing and evaluating investment opportunities, as well as providing strategic guidance to LiveOak’s portfolio companies. He is the sixth member of the firm’s investment team, working closely

PE-backed Lucid Group acquires Healthcare 21

Lucid Group, a portfolio company of private equity investor LDC and a specialist in healthcare communications, has acquired healthcare consultancy Healthcare 21. Lucid Group currently comprises five medical communications specialists, Bluedog, Leading Edge, Lighthouse, Lucid Partners and ViVid. HealthCare21 meanwhile, has been producing healthcare materials and programmes for its clients,

KKR makes major investment in Burning Glass

KKR has acquired a majority stake in Burning Glass Technologies, a real-time labour market data source, from Providence Strategic Growth. Financial details of the transaction have not been disclosed. The investment is part of KKR’s Global Impact strategy, which is focused on identifying and investing behind companies whose core business

Great Rock Capital expands origination team

Great Rock Capital, an asset-focused commercial finance company specialising in middle market lending, has appointed Ronnie Bloom as Managing Director of Originations. Bloom will be based in Toronto and will be responsible for building relationships, sourcing investment opportunities, and driving the continued expansion of the firm’s footprint in the Canadian market.   “We

Drooms makes senior appointments to UK sales team

Drooms, a provider of secure cloud solutions in Europe, is strengthening its presence in the UK with the appointments of Ditte Nielsen as Senior Business Development Manager and Alessandra Azzena as Business Development Manager. Nielsen and Azzena will be responsible for the development of business relationships, with a focus on

Pappas Capital, an investor in early-stage life sciences companies, has appointed Alex Arfaei as a Partner of Pappas Ventures.

Arfaei will be responsible for helping to identify and evaluate investment opportunities for the firm’s venture capital business. Previously, he  served as a Managing Director with BMO Capital Markets, where he was a senior equity research analyst covering major pharmaceutical and biotechnology companies. “Alex’s unique combination of equity research and

Events

12 November, 2026 – 5:00 pm

Directory Listings